AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36929955 — intervention group
Group type: EXPERIMENTAL
Intervention: Change4Life Food Scanner app (version 1.6) for 3 months
Number of subjects: 126
Study 36929955 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 126
Study 36929955 — intervention group
Group type: EXPERIMENTAL
Intervention: Change4Life Food Scanner app
Number of subjects: 126
Study 32375348 — intervention group
Group type: EXPERIMENTAL
Intervention: 6000 IU/d cholecalciferol (vitamin D)
Number of subjects: 28
Study 32375348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 32375348 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural sun exposure (WSE)
Number of subjects: 28
Study 32375348 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural sun exposure (SSE)
Number of subjects: 28
Study 34444656 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg of body mass)
Number of subjects: 11
Study 34444656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 32047952 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorite music (Group M)
Number of subjects: 117
Study 32047952 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Group C)
Number of subjects: 117
Study 36246968 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilization combined with cervical isometric exercises
Number of subjects: 88
Study 36246968 — intervention group
Group type: COMPARATOR
Intervention: Cervical isometric exercises alone
Number of subjects: 88
Study 33906239 — intervention group
Group type: EXPERIMENTAL
Intervention: Active break intervention (N=47)
Number of subjects: 193
Study 33906239 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural shift intervention (N=46)
Number of subjects: 193
Study 33906239 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=100)
Number of subjects: 193
Study 32475989 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine infusion
Number of subjects: 30
Study 32475989 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 30
Study 36201455 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g/day of fermented vegetables (group A)
Number of subjects: 31
Study 36201455 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g/day pickled vegetables (group B)
Number of subjects: 31
Study 36201455 — intervention group
Group type: COMPARATOR
Intervention: No vegetables (group C)
Number of subjects: 31
Study 34377210 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Schools educational programs
Number of subjects: 590
Study 33208512 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA-IM)
Number of subjects: 7829
Study 33208512 — intervention group
Group type: COMPARATOR
Intervention: Copper intrauterine device (IUD)
Number of subjects: 7829
Study 33208512 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 7829
Study 33342434 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 95
Study 33342434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 35924603 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless technique
Number of subjects: 24
Study 35924603 — intervention group
Group type: COMPARATOR
Intervention: Flap technique
Number of subjects: 24
Study 34189135 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion during general anesthesia
Number of subjects: 129
Study 34189135 — intervention group
Group type: COMPARATOR
Intervention: Control group (no norepinephrine)
Number of subjects: 129
Study 32958495 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 3100
Study 32958495 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir + SoC
Number of subjects: 3100
Study 32958495 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir + SoC
Number of subjects: 3100
Study 32958495 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir associated with interferon (IFN)‐β‐1a + SoC
Number of subjects: 3100
Study 32958495 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine + SoC
Number of subjects: 3100
Study 36273481 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofilament suture
Number of subjects: 2049
Study 36273481 — intervention group
Group type: COMPARATOR
Intervention: Braided suture
Number of subjects: 2049
Study 32502164 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergames during three 40-minute classes
Number of subjects: 140
Study 32502164 — intervention group
Group type: COMPARATOR
Intervention: Traditional PE classes (three routine curricular classes)
Number of subjects: 140
Study 35025817 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly subcutaneous injection
Number of subjects: 467
Study 35025817 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 467
Study 34391876 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal nonopioid analgesic protocol
Number of subjects: 48
Study 34391876 — intervention group
Group type: COMPARATOR
Intervention: Standard opioid regimen
Number of subjects: 48
Study 34391876 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study 32622171 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS at 2 mA for 15 sessions
Number of subjects: 0
Study 32622171 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study 35256899 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilator‐assisted ventilation nursing combined with mechanical vibration
Number of subjects: 120
Study 35256899 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing intervention
Number of subjects: 120
Study 33094652 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful breathing
Number of subjects: 75
Study 33094652 — intervention group
Group type: EXPERIMENTAL
Intervention: Body scan
Number of subjects: 75
Study 33094652 — intervention group
Group type: EXPERIMENTAL
Intervention: Observing-thoughts meditation
Number of subjects: 75
Study 33094652 — intervention group
Group type: COMPARATOR
Intervention: Active control (reading and discussing a book about mindfulness)
Number of subjects: 75
Study 32756643 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic therapy (Lactobacillus para casei LPC‐37, Lactobacillus rhamnosus HN001, Lactobacillus acidophilus NCFM, Bifidobacterium lactis HN019, 109 CFU of each strain) for 8 weeks
Number of subjects: 40
Study 32756643 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic therapy
Number of subjects: 40
Study 32756643 — intervention group
Group type: COMPARATOR
Intervention: Placebo (polydextrose 1 g day‐1 for 8 weeks)
Number of subjects: 40
Study 36001989 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg BID with aspirin 100 mg
Number of subjects: 0
Study 36001989 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg daily alone
Number of subjects: 0
Study 34319665 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital diagnostic waxing (DW)
Number of subjects: 20
Study 34319665 — intervention group
Group type: COMPARATOR
Intervention: Conventional diagnostic waxing (DW)
Number of subjects: 20
Study 34235978 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating biomarkers (6 selected: glial cell‐derived neurotrophic factor, glial fibrillary acidic protein, S100 calcium‐binding protein B, stem cell factor, fibroblast growth factor [FGF] 23, FGF19)
Number of subjects: 80
Study 36187334 — intervention group
Group type: EXPERIMENTAL
Intervention: RP jelly drink
Number of subjects: 43
Study 36187334 — intervention group
Group type: COMPARATOR
Intervention: Placebo jelly drink
Number of subjects: 43
Study 33742324 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intervention
Number of subjects: 40
Study 33742324 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 40
Study 32051025 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention focused on reducing sedentary time through individually tailored, progressive goals to replace sedentary time with standing and light-intensity activities.
Number of subjects: 0
Study 32051025 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study 35830143 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral fluoride gel (NFG)
Number of subjects: 240
Study 35830143 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish (FV)
Number of subjects: 240
Study 33050974 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages focusing on 'benefits' of packing healthy lunchboxes
Number of subjects: 511
Study 33050974 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages focusing on 'barriers' of packing healthy lunchboxes
Number of subjects: 511
Study 33050974 — intervention group
Group type: COMPARATOR
Intervention: Messages from different sources (dietitian, university, health promotion team, school)
Number of subjects: 511
Study 33050974 — intervention group
Group type: COMPARATOR
Intervention: Personalised messages based on child's name or grade level
Number of subjects: 511
Study 36075594 — intervention group
Group type: EXPERIMENTAL
Intervention: Scraping needling technique combined with western medication
Number of subjects: 68
Study 36075594 — intervention group
Group type: COMPARATOR
Intervention: Simple western medication (control group)
Number of subjects: 68
Study 34914281 — intervention group
Group type: EXPERIMENTAL
Intervention: CS+JJP
Number of subjects: 90
Study 34914281 — intervention group
Group type: COMPARATOR
Intervention: CS
Number of subjects: 90
Study 34914281 — intervention group
Group type: COMPARATOR
Intervention: JJP
Number of subjects: 90
Study 36041176 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet made entirely from organic foods
Number of subjects: 27
Study 36041176 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean Diet made from conventional foods
Number of subjects: 27
Study 32020130 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PRF application after surgical removal of impacted third molar
Number of subjects: 18
Study 32020130 — intervention group
Group type: COMPARATOR
Intervention: No graft inserted after extraction (Control)
Number of subjects: 18
Study 32844679 — intervention group
Group type: EXPERIMENTAL
Intervention: HBT+ACT
Number of subjects: 102
Study 32844679 — intervention group
Group type: COMPARATOR
Intervention: HBT
Number of subjects: 102
Study 33027708 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 min of skin‐to‐skin contact
Number of subjects: 88
Study 33027708 — intervention group
Group type: COMPARATOR
Intervention: 5 min of visual contact with their mother
Number of subjects: 88
Study 35018760 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamazole treatment for 5-8 months
Number of subjects: 135
Study 35018760 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamazole treatment for 9-12 months
Number of subjects: 135
Study 35018760 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamazole treatment for more than 12 months
Number of subjects: 135
Study 35018760 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study 36314172 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegoprazan 25 mg
Number of subjects: 351
Study 36314172 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 15 mg
Number of subjects: 351
Study 34233975 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 2200
Study 34233975 — intervention group
Group type: COMPARATOR
Intervention: Multivitamin
Number of subjects: 2200
Study 33123304 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief acceptance and commitment therapy (individual condition)
Number of subjects: 7
Study 33123304 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief acceptance and commitment therapy (group condition)
Number of subjects: 7
Study 33123304 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 7
Study 35100768 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents
Number of subjects: 300
Study 35100768 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents
Number of subjects: 300
Study 35100768 — intervention group
Group type: COMPARATOR
Intervention: Other topics
Number of subjects: 300
Study 34620199 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (10-h restricted feeding treatment program; ad libitum feeding from 8:00 to 18:00 h; fasting between 18:00 and 8:00 h) for 12 weeks
Number of subjects: 120
Study 34620199 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding
Number of subjects: 120
Study 35078268 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (OBTX‐A) injection
Number of subjects: 0
Study 35078268 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacral neuromodulation (SNM)
Number of subjects: 0
Study 35078268 — intervention group
Group type: COMPARATOR
Intervention: Human expert predictions
Number of subjects: 0
Study 33651384 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercises performed twice a day for 5 days
Number of subjects: 67
Study 33651384 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study 35388776 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for 5 weeks
Number of subjects: 0
Study 35388776 — intervention group
Group type: COMPARATOR
Intervention: Group-based face-to-face cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 35388776 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (WL)
Number of subjects: 0
Study 34498941 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer instruction (n = 93)
Number of subjects: 186
Study 34498941 — intervention group
Group type: COMPARATOR
Intervention: Conventional group work (n = 93)
Number of subjects: 186
Study 33212796 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers with 3 months of ≥25% decrease in cotinine levels
Number of subjects: 90
Study 33212796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low caregiver cotinine levels
Number of subjects: 90
Study 33212796 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver anxiety and depression outcomes (measured by PHQ-4 scores)
Number of subjects: 90
Study 36418137 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suture with additional interrupted retention sutures (MonoMax 1 and Vicryl 2)
Number of subjects: 222
Study 36418137 — intervention group
Group type: COMPARATOR
Intervention: Standard continuous suture (MonoMax 1)
Number of subjects: 222
Study 33143906 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational peer group intervention (two interactive group sessions)
Number of subjects: 319
Study 32710787 — intervention group
Group type: EXPERIMENTAL
Intervention: 15N-labeled milk protein concentrate (25 g - low protein)
Number of subjects: 10
Study 32710787 — intervention group
Group type: EXPERIMENTAL
Intervention: 15N-labeled milk protein concentrate (50 g - high protein)
Number of subjects: 10
Study 32710787 — intervention group
Group type: EXPERIMENTAL
Intervention: 15N-labeled milk protein (high protein)
Number of subjects: 10
Study 33719775 — intervention group
Group type: EXPERIMENTAL
Intervention: TOWER intervention
Number of subjects: 40
Study 33719775 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 34491113 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame-based dual-task training
Number of subjects: 20
Study 34491113 — intervention group
Group type: COMPARATOR
Intervention: Home-based multicomponent exercise training
Number of subjects: 20
Study 34254976 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher abdominal fat deposition
Number of subjects: 755
Study 34254976 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher waist circumference (WC)
Number of subjects: 755
Study 34254976 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher hip circumference (HC)
Number of subjects: 755
Study 34254976 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-hip ratio (WHR)
Number of subjects: 755
Study 32072742 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi (n = 255)
Number of subjects: 512
Study 32072742 — intervention group
Group type: COMPARATOR
Intervention: iGlar (n = 257)
Number of subjects: 512
Study 32072742 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 512
Study 32072742 — intervention group
Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 512
Study 33066723 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecopipam (25–100 mg/day)
Number of subjects: 10
Study 33066723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33867497 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise Training (RET)
Number of subjects: 35
Study 33867497 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 35
Study 33867497 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Exercise Training (ENT)
Number of subjects: 35
Study 33867497 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining after RET and HIIT
Number of subjects: 35
Study 35172928 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal amplifier
Number of subjects: 11
Study 35172928 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing screening
Number of subjects: 11
Study 34836058 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of CMR (3% - 750 mg)
Number of subjects: 14
Study 34836058 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of CMR (2% - 500 mg)
Number of subjects: 14
Study 34836058 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of CMR (1% - 250 mg)
Number of subjects: 14
Study 34836058 — intervention group
Group type: COMPARATOR
Intervention: Sweetened water (placebo)
Number of subjects: 14
Study 35704122 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 30
Study 35704122 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling with Vibration (VFR)
Number of subjects: 30
Study 32297719 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine extended-release (GXR)
Number of subjects: 201
Study 32297719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 37714408 — intervention group
Group type: EXPERIMENTAL
Intervention: Beam F3 targeting (n=58)
Number of subjects: 105
Study 37714408 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5 cm targeting (n=47)
Number of subjects: 105
Study 35409532 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching group (n = 26) participated in a 7-day guided hiking program with three personal coaching sessions
Number of subjects: 58
Study 35409532 — intervention group
Group type: COMPARATOR
Intervention: Hiking group (n = 32) received no coaching
Number of subjects: 58
Study 32139384 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin increased by ≥1,000 mg/day
Number of subjects: 6823
Study 32139384 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin unchanged
Number of subjects: 6823
Study 32139384 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin decreased
Number of subjects: 6823
Study 36461899 — intervention group
Group type: EXPERIMENTAL
Intervention: STN-DBS
Number of subjects: 201
Study 36461899 — intervention group
Group type: COMPARATOR
Intervention: BMT
Number of subjects: 201
Study 33581721 — intervention group
Group type: EXPERIMENTAL
Intervention: ANI-guided group (loading dose of 75 μg of fentanyl followed by 25 μg when ANI score was under 50)
Number of subjects: 60
Study 33581721 — intervention group
Group type: COMPARATOR
Intervention: Control group (same loading dose followed by 25 μg every 30 min with additional doses for inadequate analgesia)
Number of subjects: 60
Study 33581721 — intervention group
Group type: EXPERIMENTAL
Intervention: ANI-guided group
Number of subjects: 60
Study 33581721 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34592491 — intervention group
Group type: EXPERIMENTAL
Intervention: Storytelling method (n=40)
Number of subjects: 70
Study 34592491 — intervention group
Group type: COMPARATOR
Intervention: Lecture method (n=30)
Number of subjects: 70
Study 34592491 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 70
Study 32967413 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcapsular anesthesia (SA)
Number of subjects: 323
Study 32967413 — intervention group
Group type: COMPARATOR
Intervention: Pericapsular anesthesia (PA)
Number of subjects: 323
Study 32269181 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.066 mg/kg/day GH
Number of subjects: 51
Study 32269181 — intervention group
Group type: COMPARATOR
Intervention: 0.033 mg/kg/day GH
Number of subjects: 51
Study 32269181 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study 32160171 — intervention group
Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 60
Study 32160171 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 34077291 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0
Study 34077291 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 0
Study 33081476 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified rubber band ligation (MRBL)
Number of subjects: 120
Study 33081476 — intervention group
Group type: COMPARATOR
Intervention: Milligan‐Morgan haemorrhoidectomy (MMH)
Number of subjects: 120
Study 33081476 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MRBL and MMH
Number of subjects: 120
Study 35679212 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma exposure (direct, witnessed, and indirect)
Number of subjects: 87
Study 35679212 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience
Number of subjects: 87
Study 35679212 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate regression models for posttraumatic stress and anxiety
Number of subjects: 87
Study 34933316 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine in 70% alcohol
Number of subjects: 482
Study 34933316 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine in aqueous solution
Number of subjects: 482
Study 32990206 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol monotherapy
Number of subjects: 277